Has Susan Taylor, MD received payments from drug or device companies?

Yes. Drug and device makers reported $206,966 in general payments to Susan Taylor, MD across 140 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Susan Taylor, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Susan Taylor, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Susan Taylor, MD

Dermatology · Philadelphia, PANPI 1962546952

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $172,758 of the $206,966 with a category attached, or 83.5%. 23 manufacturers reported payments, led by AbbVie at 29.1% of the total. Reporting peaked in 2022 at $65,333 and has fallen 60.5% since, to $25,790 in 2025. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$206,966in general payments, 2019–2025

Across 140 payments — averaging $1478.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$60K
Eli Lilly$49K
Lilly USA, LLC$19K
E.r. Squibb & Sons, L.L.C.$16K
Incyte Corporation$13K
UCB, Inc.$9K
plus $41K from 17 others

$736,178in research payments, 2019–2025

Across 67 payments — averaging $10,988 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$518K
Sun Pharmaceutical Industries Inc.$157K
Kyowa Kirin, Inc.$35K
AbbVie$25K
Pfizer$940

What the payments were for

Consulting fees$172,75883%
Speaking & faculty fees$13,1306%
Travel & lodging$17,5098%
Food & beverage$3,5692%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	22	$60,238
Eli Lilly	28	$48,893
Lilly USA, LLC	8	$18,704
E.r. Squibb & Sons, L.L.C.	14	$15,565
Incyte Corporation	9	$12,896
UCB, Inc.	11	$9,388
Johnson & Johnson	8	$8,752
Sanofi	1	$7,902
Pfizer	6	$4,889
EPI Health, LLC	3	$4,695
Janssen Scientific Affairs, LLC	4	$3,649
Regeneron	4	$3,335
Janssen Global Services, LLC	3	$2,111
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$1,996
Avita Medical Americas, LLC	2	$1,500
Galderma Laboratories, L.p.	2	$1,349
Sun Pharmaceutical Industries Inc.	3	$416
Almirall LLC	4	$284
Solta Medical, A Division Of Bausch Health US, LLC	1	$116
Regeneron Healthcare Solutions, Inc.	1	$105
Arcutis Biotherapeutics, Inc.	1	$76
Novartis	1	$56
Merz North America, Inc.	1	$52

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BOTOX$17,600
OPZELURA$12,812
Tremfya$12,140
DUPIXENT$11,295
EBGLYSS$6,750
Skyrizi$6,580
OLUMIANT$5,400
WYNZORA$4,600
CIBINQO$4,250
Rinvoq$4,019
ALTRENO$1,800
RECELL$1,500
SOOLANTRA$1,349
ILUMYA$416
ODOMZO$281
BLU-U$136
DUOBRII$126

How this compares

$206,966 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$13,445

Medicare patients

Services billed

188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	93	$5,340
Doxycycline Hyclate	35	$934
Doxycycline Monohydrate	43	$919
Hydroxychloroquine Sulfate	14	$660
Dutasteride	14	$586
Minoxidil	42	$446
Finasteride	23	$226
Ketoconazole	20	$167
Triamcinolone Acetonide	11	$52

Paid to pharmacies, not to this prescriber.

Other dermatology in Philadelphia

Stephen HessPhiladelphia$1.7M
Joel GelfandPhiladelphia$649K
Victoria WerthPhiladelphia$547K
Nicholas MollanazarPhiladelphia$369K
Harold FarberPhiladelphia$284K
Jules LipoffPhiladelphia$259K
Joy WanPhiladelphia$176K
Harold MilsteinPhiladelphia$120K
David MargolisPhiladelphia$118K
Naeha GuptaPhiladelphia$105K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →